Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
00:47:23 EDT Thu 02 May 2024
Enter Symbol
or Name
USA
CA



News for U:APTO from 2023-05-03 to 2024-05-02 - 25 items News ReleasesIn The NewsOther CAUS
DateSymPriceTypeHeadline
2024-03-26 16:01U:APTONews ReleaseAptose Reports Results for the Fourth Quarter and Full Year 2023
2024-03-18 16:30U:APTONews ReleaseAptose to Report Fourth Quarter and Year End 2023 Financial Results and Provide Corporate Update on Tuesday, March 26, 2024
2024-01-31 16:01U:APTONews ReleaseAptose Announces Closing of $9.7 Million Public Offering and Concurrent $4 Million Private Placement with Hanmi Pharmaceutical, Including Full Exercise of Over-Allotment Option
2024-01-26 08:00U:APTONews ReleaseAptose Announces Pricing of $8.4 Million Public Offering and a Concurrent $4 Million Private Placement with Hanmi Pharmaceutical
2023-12-09 18:30U:APTONews ReleaseAptose Tuspetinib Clinical Data Featured in Oral Presentation at the 2023 ASH Annual Meeting
2023-11-30 17:00U:APTONews ReleaseAptose Appoints Fletcher Payne Chief Business Officer, Expanding his Executive Role
2023-11-09 16:00U:APTONews ReleaseAptose Reports Results for the Third Quarter 2023
2023-11-02 09:00U:APTONews ReleaseAptose Tuspetinib Clinical Data Selected for Oral Presentation ‚  at the 2023 ASH Annual Meeting
2023-10-30 09:15U:APTONews ReleaseAptose Presents Highlights from Clinical Update Webcast Featuring Latest Available Data on AML Drug Tuspetinib
2023-10-26 07:11U:APTONews ReleaseAptose to Report Third Quarter 2023 Financial Results and Hold Conference Call on Thursday, November 9, 2023
2023-10-23 07:30U:APTONews ReleaseAptose to Hold Clinical Update and KOL Data Review of AML Drug Tuspetinib on Monday, October 30th
2023-10-16 07:30U:APTONews ReleaseAptose Clinical and Preclinical Data to be Presented at European School of Haematology (ESH) 6th International Conference
2023-09-18 07:45U:APTONews ReleaseAptose to Present at the Cantor Global Healthcare Conference
2023-09-06 07:45U:APTONews ReleaseAptose Announces Closing of $3 Million Investment by Hanmi Pharmaceutical
2023-08-24 07:30U:APTONews ReleaseAptose to Present at the H.C. Wainwright 25th Annual Global Investment Conference
2023-08-10 16:02U:APTONews ReleaseAptose Reports Results for the Second Quarter 2023
2023-07-27 16:04U:APTONews ReleaseAptose to Report Second Quarter 2023 Financial Results and ‚  Hold Conference Call on Thursday, August 10, 2023
2023-06-26 16:05U:APTONews ReleaseAptose Biosciences Meets Nasdaq Minimum Bid Price Compliance
2023-06-10 12:00U:APTONews ReleaseAptose Presents Highlights from Clinical Update
2023-06-05 07:30U:APTONews ReleaseAptose Biosciences Provides Update on Reverse Stock Split
2023-05-31 07:30U:APTONews ReleaseAptose to Hold Interim Clinical Update Webcast on Saturday, June 10, 2023
2023-05-25 16:15U:APTONews ReleaseAptose Enters into $25 Million Committed Equity Facility
2023-05-23 17:30U:APTONews ReleaseAptose Biosciences Announces Results of Annual and Special Meeting of Shareholders
2023-05-08 16:01U:APTONews ReleaseAptose Reports Results for the First Quarter 2023
2023-05-04 07:01U:APTONews ReleaseAptose to Participate in RBC Capital Markets 2023 Global Healthcare Conference